Quick Takeaways
- Voss Capital, LP filed SCHEDULE 13G/A for ACTUATE THERAPEUTICS, INC. Common Stock, par value $0.000001 per share (ACTU).
- Disclosed ownership: 7.7%.
- Date of event: 31 Mar 2026.
Quoteable Key Fact
"Voss Capital, LP disclosed 7.7% ownership in ACTUATE THERAPEUTICS, INC. Common Stock, par value $0.000001 per share (ACTU) on 31 Mar 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Voss Capital, LP | 7.7% | 1,814,263 | 1,400,000 | 414,263 | /s/ Travis W. Cocke | Travis W. Cocke, Managing Member | |
| Cocke Travis W. | 7.7% | 1,814,263 | 1,400,000 | 414,263 | /s/ Travis W. Cocke | Travis W. Cocke | |
| Voss Advisors GP, LLC | 1.5% | 350,000 | 350,000 | 0 | /s/ Travis W. Cocke | Travis W. Cocke, Managing Member | |
| Voss Value Master Fund, LP | 1.3% | 300,000 | 300,000 | 0 | /s/ Travis W. Cocke | Travis W. Cocke, Managing Member of Voss Advisors GP, LLC, its General Partner | |
| Voss Value-Oriented Special Situations Fund, LP | 0.2% | 50,000 | 50,000 | 0 | /s/ Travis W. Cocke | Travis W. Cocke, Managing Member of Voss Advisors GP, LLC, its General Partner |